Singapore - A drug to treat childhood epilepsy is expected this week to become the first medicine derived from cannabis to be approved for sale in the U.S.
GW Pharmaceuticals has raised $1B from American healthcare funds during the past five years to develop Epidiolex.
FDA clearance would pave the way for the drug to be launched nationwide by the fall.
